Literature DB >> 10943543

Toxic epidermal necrolysis.

P Wolkenstein1, J Revuz.   

Abstract

Toxic epidermal necrolysis (TEN) is a rare but life-threatening adverse drug reaction. Implicated drugs are sulfonamides, anticonvulsants, allopurinol, and pyrazolone derivatives. Recently, advances in pathogenesis have been made in two directions. It is now known that (1) most patients with TEN have an abnormal metabolism to the culprit drug; and (2) the mechanism leading to epidermal necrolysis seems to be a cell-mediated cytotoxic reaction. The treatment remains symptomatic.

Entities:  

Mesh:

Year:  2000        PMID: 10943543     DOI: 10.1016/s0733-8635(05)70196-0

Source DB:  PubMed          Journal:  Dermatol Clin        ISSN: 0733-8635            Impact factor:   3.478


  5 in total

1.  Toxic epidermal necrolysis induced by a triple-drug regimen for helicobacter pylori eradication.

Authors:  Yoshihiro Matsukawa; Hiroyuki Hara; Masanori Aoki; Kentaro Inada; Motohide Kaneko; Ko Mitamura; Umihiko Sawada; Shigemasa Sawada; Takashi Horie; Toyoko Ochiai
Journal:  Clin Drug Investig       Date:  2004       Impact factor: 2.859

2.  Toxic Epidermal Necrolysis : A Case Report.

Authors:  N Kumar; N S Walia; M S Sandhu; N Grover
Journal:  Med J Armed Forces India       Date:  2011-07-21

3.  Use of the Biopharmaceutics Drug Disposition Classification System (BDDCS) to Help Predict the Occurrence of Idiosyncratic Cutaneous Adverse Drug Reactions Associated with Antiepileptic Drug Usage.

Authors:  Rosa Chan; Chun-Yu Wei; Yuan-Tsong Chen; Leslie Z Benet
Journal:  AAPS J       Date:  2016-03-07       Impact factor: 4.009

4.  A case of toxic epidermal necrolysis caused by trimethoprim-sulfamethoxazole.

Authors:  Jharendra P Rijal; Tiffany Pompa; Smith Giri; Vijaya Raj Bhatt
Journal:  BMJ Case Rep       Date:  2014-07-09

Review 5.  Skin manifestations of drug reactions.

Authors:  James Q Del Rosso
Journal:  Curr Allergy Asthma Rep       Date:  2002-07       Impact factor: 4.919

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.